HIV protease inhibitors based on amino acid derivatives

JOURNAL ARTICLE published April 2003 in Expert Opinion on Therapeutic Patents

Novel substituted 2,3-benzodiazepin-4-ones as non-competitive AMPA antagonists and positive modulators

JOURNAL ARTICLE published July 1998 in Expert Opinion on Therapeutic Patents

Clinical potential of the HA-1 peptide, a minor histocompatibility antigen

JOURNAL ARTICLE published October 1999 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published July 2005 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published December 2000 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published January 2005 in Expert Opinion on Therapeutic Patents

Phosphodiesterase 4 inhibitors

JOURNAL ARTICLE published November 1997 in Expert Opinion on Therapeutic Patents

Protease-activated drug delivery

JOURNAL ARTICLE published 2003 in Expert Opinion on Therapeutic Patents

Small molecule IL-4 antagonists

JOURNAL ARTICLE published July 2002 in Expert Opinion on Therapeutic Patents

Merck & Co.: updated analysis of patenting with comparative data for thirty-five companies

JOURNAL ARTICLE published August 1997 in Expert Opinion on Therapeutic Patents

Authors: Peter R Steele

Patent Evaluation Central & Peripheral Nervous Systems: Neuronal sodium/calcium channel blockers as therapeutics for stroke and epilepsy

JOURNAL ARTICLE published September 1996 in Expert Opinion on Therapeutic Patents

Further improvements in the technology of HSV-1-based amplicon vectors

JOURNAL ARTICLE published July 2008 in Expert Opinion on Therapeutic Patents

Authors: Delphine Cuchet | Alberto L Epstein

Vascular endothelial growth factor tyrosine kinase inhibitors

JOURNAL ARTICLE published June 2004 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published May 2001 in Expert Opinion on Therapeutic Patents

Cyclodextrins improving the physicochemical and pharmacological properties of antidepressant drugs: a patent review

JOURNAL ARTICLE published 2 January 2018 in Expert Opinion on Therapeutic Patents

Authors: Tâmara Coimbra Diniz | Tiago Coimbra Costa Pinto | Paula dos Passos Menezes | Juliane Cabral Silva | Roxana Braga de Andrade Teles | Rosana Christine Cavalcanti Ximenes | Adriana Gibara Guimarães | Mairim Russo Serafini | Adriano Antunes de Souza Araújo | Lucindo José Quintans Júnior | Jackson Roberto Guedes da Silva Almeida

Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents

JOURNAL ARTICLE published January 2010 in Expert Opinion on Therapeutic Patents

Authors: Andrew J King | Andrew S Judd | Andrew J Souers

An overview on recent patents and technologies on nanoparticles for nucleic acid delivery

JOURNAL ARTICLE published 3 March 2024 in Expert Opinion on Therapeutic Patents

Research funded by CNPq Brazil – “Conselho Nacional de Desenvolvimento Científico e Tecnológico” ((Grant Number 424911/2021-3))

Authors: Larissa Moraes dos Santos Fonseca | Bruna Aparecida Souza Machado | Fabricia Oliveira Oliveira | Jânio Rodrigo de Jesus Santos | Jaqueline Wang da Silva | Katharine Valeria Saraiva Hodel | Brisa Gonçalves Rosatti | Claudio Damasceno Pinto | Milena Botelho Pereira Soares

Marine natural products as therapeutic agents

JOURNAL ARTICLE published September 1999 in Expert Opinion on Therapeutic Patents

Authors: Russell G Kerr | Stacey S Kerr

Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010 – 2015; part 2)

JOURNAL ARTICLE published 1 November 2016 in Expert Opinion on Therapeutic Patents

Research funded by Korea Institute of Science and Technology (2N41660) | National Research Council of Science & Technology (NST) grant by the Korea government (CRC-15-04-KIST)

Authors: TaeHun Kim | Ae Nim Pae

Cardiovascular & Renal: AT₂antagonist inhibition of vascular restenosis

JOURNAL ARTICLE published June 1995 in Expert Opinion on Therapeutic Patents